News
Venture Challenge Spring 2024 has kicked-off
The Venture Challenge Spring 2024 Kicked-off this week at Pivot Park. Six teams eager to bring their inventions to market joined us in the first 3-day bootcamp.
Apply now for the Venture Challenge fall 2024
On 7 May 2024 a new application round of the Venture Challenge has opened. During the 10-week Venture Challenge program starting entrepreneurs in lifesciences are guided in developing their business plan and starting a company. The deadline for applying is 2 July, 2024 14:00.
3D-PharmXchange is now part of our Innovation Broaker network!
We are happy to welcome 3D-PharmXchange as a new member of our Innovation Broaker network! From now on Dutch startups and scaleups in drug development can start a project with 3D-PharmXhange and make use of the Innovation Broaker subsidy.
Dan Jing Wu with Vivart-X receives Henri Termeer Transatlantic Connections Award
Prestigious Award Given to Co-Founder of Tissue Regeneration Company Focused on Women’s Health
SME Call: Entrepreneurs leading the way….
Building on the momentum of a triumphant start in 2023, the success of our pilot SME call has paved the way for its continuation into 2024. For this reason, a perfect timing to dive deeper into the call. For this purpose, we spoke to Jochem Christiaansen from Health~Holland and Robbert Wever from hollandbio, both involved in the setup of the call from the beginning. In addition, we invited Aisling Foley and Ilaria Poledri, founders of ExCulture B.V. for an interview to talk more about their experience as applicants within the pilot call.
LifeSciences@Work high in the Financial Times list of Europe's Leading Startup Hubs
Great news! The Financial Times took on the project to map out Europe’s incubators and accelerators boosting tech entrepreneurship.
Venture Challenge evaluated to be highly effective and efficient
The Venture Challenge subsidy module expires in 2025, it is up to the ministry to assess whether and how the program should continue. Therefore, an evaluation was conducted by an independent, external party, Birch. This article outlines the highlights of the 52 pages full report that was presented to the Dutch Parliament.
ALS Medication Development Hits Roadblock but Holds Promise: Insights from Treeway CEO
An interview with Inez de Greef, CEO Treeway Translated from Dutch, original article from the VIG
Scope BioSciences Secures €2.5 Million EIC-Transition Grant
Wageningen, The Netherlands – Venture Challenge alumnus Scope Biosciences announces the award of a €2.5 million EIC Transition grant, a testament to its groundbreaking work in molecular diagnostics.
Operating with VR: 'Erasmus MC Can't Do Without'
Translated from Dutch Original author: Thijs Baas